Plasma Metabolomics for Discovery of Early Metabolic Markers of Prostate Cancer Based on Ultra-High-Performance Liquid Chromatography-High Resolution Mass Spectrometry

SIMPLE SUMMARY: Correct identification of subjects at high risk is critical in the prevention and early screening of prostate cancer (PCa). Analysis of metabolites in biofluids has shown to be a promising method to identify novel PCa biomarkers. To identify potential biomarkers of PCa, we conducted...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Xiangping, Lécuyer, Lucie, Liu, Xinyu, Triba, Mohamed N., Deschasaux-Tanguy, Mélanie, Demidem, Aïcha, Liu, Zhicheng, Palama, Tony, Rossary, Adrien, Vasson, Marie-Paule, Hercberg, Serge, Galan, Pilar, Savarin, Philippe, Xu, Guowang, Touvier, Mathilde
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8268247/
https://www.ncbi.nlm.nih.gov/pubmed/34201735
http://dx.doi.org/10.3390/cancers13133140

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8268247/
https://www.ncbi.nlm.nih.gov/pubmed/34201735
http://dx.doi.org/10.3390/cancers13133140

Ejemplares similares